Literature DB >> 2555688

Possible involvement of normal p21 H-ras in the insulin/insulinlike growth factor 1 signal transduction pathway.

B M Burgering1, A J Snijders, J A Maassen, A J van der Eb, J L Bos.   

Abstract

Expression of a mutant H-ras gene confers a transformed phenotype to rat-1 fibroblasts which is basically independent of exogenous growth factors (GFs). Rat-1 cells induced to express high levels of the normal H-ras gene were also found to display a transformed phenotype. In contrast to cells expressing mutant H-ras, these cells were dependent on GFs. We used this difference in GF dependence to analyze a possible involvement of exogenous GFs in H-ras function. Compared with untransformed rat-1 cells, cells overexpressing normal H-ras displayed an elevated response toward insulinlike growth factor 1 (IGF-1), insulin, and bombesin and an increased sensitivity toward phosphatidic acids. It was found that 8-bromo-cyclic AMP inhibited the responses to all GFs in rat-1 cells but had no effect on mutant-H-ras-transformed cells. In cells overexpressing normal H-ras, 8-bromo-cyclic AMP inhibited the responses to all GFs except those to insulin and IGF-1. This implies that overexpression of normal H-ras in the presence of insulin/IGF-1 is functionally similar to the expression of mutant H-ras, since mutant H-ras can circumvent this block by itself. These and other results strongly suggest a functional linkage between insulin/IGF-1 and normal p21 H-ras.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555688      PMCID: PMC362512          DOI: 10.1128/mcb.9.10.4312-4322.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH 3T3 cells.

Authors:  E Finzi; T Fleming; O Segatto; C Y Pennington; T S Bringman; R Derynck; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

Review 2.  The glucose transporter of mammalian cells.

Authors:  T J Wheeler; P C Hinkle
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

3.  Role of guanine nucleotide binding protein in the activation of polyphosphoinositide phosphodiesterase.

Authors:  S Cockcroft; B D Gomperts
Journal:  Nature       Date:  1985 Apr 11-17       Impact factor: 49.962

4.  Phenotypic transformation of normal rat kidney cells in a growth-factor-defined medium: induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor.

Authors:  E J van Zoelen; T M van Oostwaard; P T van der Saag; S W de Laat
Journal:  J Cell Physiol       Date:  1985-05       Impact factor: 6.384

5.  Insulin rapidly increases diacylglycerol by activating de novo phosphatidic acid synthesis.

Authors:  R V Farese; T S Konda; J S Davis; M L Standaert; R J Pollet; D R Cooper
Journal:  Science       Date:  1987-05-01       Impact factor: 47.728

6.  Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents.

Authors:  D F Bowen-Pope; A Vogel; R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  The p21 ras C-terminus is required for transformation and membrane association.

Authors:  B M Willumsen; A Christensen; N L Hubbert; A G Papageorge; D R Lowy
Journal:  Nature       Date:  1984 Aug 16-22       Impact factor: 49.962

8.  Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins.

Authors:  T Kamata; J R Feramisco
Journal:  Nature       Date:  1984 Jul 12-18       Impact factor: 49.962

9.  The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity.

Authors:  R W Sweet; S Yokoyama; T Kamata; J R Feramisco; M Rosenberg; M Gross
Journal:  Nature       Date:  1984 Sep 20-26       Impact factor: 49.962

10.  Yeast and mammalian ras proteins have conserved biochemical properties.

Authors:  G L Temeles; J B Gibbs; J S D'Alonzo; I S Sigal; E M Scolnick
Journal:  Nature       Date:  1985 Feb 21-27       Impact factor: 49.962

View more
  10 in total

Review 1.  The biochemistry of ras p21.

Authors:  R J Grand; D Owen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

2.  Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells.

Authors:  T Satoh; M Endo; M Nakafuku; S Nakamura; Y Kaziro
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  Alteration of homeobox gene expression by N-ras transformation of PA-1 human teratocarcinoma cells.

Authors:  R Buettner; S O Yim; Y S Hong; E Boncinelli; M A Tainsky
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

4.  Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells.

Authors:  L M Wang; A D Keegan; W Li; G E Lienhard; S Pacini; J S Gutkind; M G Myers; X J Sun; M F White; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  The ras signaling pathway mimics insulin action on glucose transporter translocation.

Authors:  L Kozma; K Baltensperger; J Klarlund; A Porras; E Santos; M P Czech
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

6.  Ras activation by insulin and epidermal growth factor through enhanced exchange of guanine nucleotides on p21ras.

Authors:  R H Medema; A M de Vries-Smits; G C van der Zon; J A Maassen; J L Bos
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

7.  Epidermal growth factor induces phosphorylation of extracellular signal-regulated kinase 2 via multiple pathways.

Authors:  B M Burgering; A M de Vries-Smits; R H Medema; P C van Weeren; L G Tertoolen; J L Bos
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

8.  Insulin stimulation of gene expression mediated by p21ras activation.

Authors:  B M Burgering; R H Medema; J A Maassen; M L van de Wetering; A J van der Eb; F McCormick; J L Bos
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

Review 9.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

10.  cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor.

Authors:  B M Burgering; G J Pronk; P C van Weeren; P Chardin; J L Bos
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.